ES8700935A1 - Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada - Google Patents

Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada

Info

Publication number
ES8700935A1
ES8700935A1 ES541394A ES541394A ES8700935A1 ES 8700935 A1 ES8700935 A1 ES 8700935A1 ES 541394 A ES541394 A ES 541394A ES 541394 A ES541394 A ES 541394A ES 8700935 A1 ES8700935 A1 ES 8700935A1
Authority
ES
Spain
Prior art keywords
dosage form
producing
long
pharmaceutical dosage
term pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541394A
Other languages
English (en)
Other versions
ES541394A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of ES8700935A1 publication Critical patent/ES8700935A1/es
Publication of ES541394A0 publication Critical patent/ES541394A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

METODO PARA LA PRODUCCION DE UNA FORMA DE DOSIFICACION FARMACEUTICA UNITARIA, DE LIBERACION PROLONGADA, INDEPENDIENTE DEL PH INTESTINAL. CONSISTE EN UNA CAPSULA DE GELATINA DURA QUE CONTIENE UNA MEZCLA EN POLVO DE UN MEDICAMENTO DE 10 A 60% EN PESO DE HIDROXIPROPILMETILCELULOSA CON UN CONTENIDO METOXI DE 16 A 24% EN PESO, UN CONTENIDO DE HIDROXIPROPILO DE 4 A 32% EN PESO Y UN PESO MOLECULAR MEDIO DE AL MENOS 50.000, Y UN COADYUVANTE SIN ACTIVIDAD TERAPEUTICA PERO FARMACOLOGICAMENTE ACEPTABLE. COMPRENDE MEZCLAR LOS INGREDIENTES CITADOS, MOLER LA MEZCLA A TEMPERATURA AMBIENTE, MOLER HASTA UN TAMAÑO DE PARTICULA UNIFORME DE LOS INGREDIENTES, MEZCLAR DE NUEVO PARA OBTENER UN PRODUCTO HOMOGENEO O CASI HOMOGENEO Y RELLENAR CON ESTE PRODUCTO LAS CAPSULAS.
ES541394A 1984-03-21 1985-03-20 Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada Expired ES8700935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59173884A 1984-03-21 1984-03-21

Publications (2)

Publication Number Publication Date
ES8700935A1 true ES8700935A1 (es) 1986-11-16
ES541394A0 ES541394A0 (es) 1986-11-16

Family

ID=24367713

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541394A Expired ES8700935A1 (es) 1984-03-21 1985-03-20 Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada

Country Status (13)

Country Link
EP (1) EP0156592A3 (es)
JP (1) JPS61501511A (es)
KR (1) KR850700212A (es)
AU (1) AU4064285A (es)
DK (1) DK529885D0 (es)
ES (1) ES8700935A1 (es)
FI (1) FI854573A7 (es)
GB (1) GB2157169A (es)
GR (1) GR850625B (es)
HU (1) HUT38262A (es)
PT (1) PT80124B (es)
WO (1) WO1985004100A1 (es)
ZA (1) ZA851891B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
IT1222414B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
DE69739165D1 (de) * 1996-07-08 2009-01-29 Penwest Pharmaceuticals Co Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration
JP5699339B2 (ja) * 2010-02-12 2015-04-08 日産化学工業株式会社 徐放性製剤
US8999393B1 (en) * 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam
BR112015016322A8 (pt) * 2013-01-09 2018-01-23 Edgemont Pharmaceuticals Llc formulações de liberação controlada de lorazepam
KR20210052281A (ko) 2019-10-29 2021-05-10 신에쓰 가가꾸 고교 가부시끼가이샤 캡슐 충전용 조성물 및 이것을 사용한 캡슐 제제의 제조 방법 그리고 캡슐 제제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.

Also Published As

Publication number Publication date
ZA851891B (en) 1986-10-29
DK529885A (da) 1985-11-15
DK529885D0 (da) 1985-11-15
FI854573L (fi) 1985-11-20
PT80124B (en) 1986-11-14
GB2157169A (en) 1985-10-23
JPS61501511A (ja) 1986-07-24
HUT38262A (en) 1986-05-28
KR850700212A (ko) 1985-12-26
FI854573A0 (fi) 1985-11-20
ES541394A0 (es) 1986-11-16
PT80124A (en) 1985-04-01
GR850625B (es) 1985-06-17
WO1985004100A1 (en) 1985-09-26
FI854573A7 (fi) 1985-11-20
AU4064285A (en) 1985-10-11
EP0156592A3 (en) 1987-03-11
GB8506656D0 (en) 1985-04-17
EP0156592A2 (en) 1985-10-02

Similar Documents

Publication Publication Date Title
ES8700935A1 (es) Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada
SE8004284L (sv) Terapeutisk preparat med forlengd, regelbunden utlosning av ett deri befintligt, terapeutiskt verksamt lekemedel
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
KR840006765A (ko) 지속성 방출 고형 제형의 제조방법
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
HUP9802252A2 (hu) D-treo-metil-fenidátot tartalmazó, késleltetett hatóanyag-felszabadítású gyógyszerkészítmény
FI906245A0 (fi) L-carnitinhaltiga preparat.
BG96513A (bg) Заместени 4-фенил-4-пиперидинкарбоксамиди с локален обезболяващ и болкоуспокояващ ефект и метод за тяхното получаване
UA12648A (uk) Спосіб одержаhhя твердої лікарської форми
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
SE8901003L (sv) Snabbloesliga preparat
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
ES535798A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina.
AR012723A1 (es) Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos
EA200300247A1 (ru) Фармацевтическая композиция, содержащая циталопрам
AR012737A1 (es) Derivados de triptolida utiles en el tratamiento de las enfermedades autoinmunes y usos en la fabricacion de medicamentos
IL51360A (en) Peptides having analgesic activity,their production and pharmaceutical compositions containing them
IT1252185B (it) Preparazioni farmaceutiche a liberazione programmata
MY100780A (en) Azumolene dosage form.
HUP9801686A2 (hu) Amino-tetralin-származék alkalmazása kardiovaszkuláris megbetegedések terápiájában használható gyógyszer előállítására
IT8026233A0 (it) Derivato della n-acetil-cisteina ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
RU95109891A (ru) 19,11-перекрытые мостиками 4-эстрены, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения для их получения
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция